Characterization of autoantibodies against components of the nuclear pore complexes: High frequency of anti-p62 nucleoporin antibodies

Józefa Wȩsierska-Ga̧dek, Anna Klima, Oxana Komina, Carmen Ranftler, Pietro Invernizzi, Edward Penner

Research output: Chapter in Book/Report/Conference proceedingConference contribution

19 Citations (Scopus)

Abstract

Antibodies against nuclear components (ANAs) occur in sera of approximately 50% of patients with primary biliary cirrhosis (PBC). By indirect immunofluorescence (IIF) ANA-positive PBC sera generate most frequently, homogeneous, speckled, centromere, and rim-like staining patterns. A perinuclear staining pattern is indicative for the reactivity of the sera with the components of the nuclear envelope. A substantial subset of PBC patients develops antibodies against constituents of the nuclear pore complexes (NPCs). These autoantibodies target two major autoantigens: gp210 glycoprotein and p62 kDa nucleoporin. Originally, a strong reaction of PBC with a 60 kDa protein of NPCs that was affinity purified on wheat-germ agglutinin (WGA)-Sepharose was described. Recently, using human recombinant p62 nucleoporin the identity of the reactivitywas confirmed. In this work we compared by immunoprecipitation the reactivity of 20 PBC sera with the two recombinant autoantigens of the NPCs. Two out of 20 (10%) PBC sera precipitated recombinant gp210 glycoprotein and 11 out of 20 (55%) PBC sera reacted with p62 nucleoporin. These results evidence that anti-p62 antibodies occur more frequently than the autoantibodies against gp210 glycoprotein. Considering the recently reported clinical significance of ANAs in PBC, the prognostic value of the anti-NPC antibodies and their correlation with severity and progression of the disease is under evaluation.

Original languageEnglish (US)
Title of host publicationAnnals of the New York Academy of Sciences
Pages519-530
Number of pages12
Volume1109
DOIs
StatePublished - Aug 2007
Externally publishedYes

Publication series

NameAnnals of the New York Academy of Sciences
Volume1109
ISSN (Print)00778923
ISSN (Electronic)17496632

Fingerprint

Nuclear Pore
Biliary Liver Cirrhosis
Autoantibodies
Antibodies
Nuclear Pore Complex Proteins
Glycoproteins
Serum
Autoantigens
Wheat Germ Agglutinins
Staining and Labeling
Sepharose
nuclear pore protein p62
Centromere
Nuclear Envelope
Indirect Fluorescent Antibody Technique
Immunoprecipitation
Disease Progression
Anti-Idiotypic Antibodies

Keywords

  • AMAs
  • ANAs
  • Gp210 glycoprotein
  • Nuclear envelope
  • Prognostic value
  • Severity of disease

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Wȩsierska-Ga̧dek, J., Klima, A., Komina, O., Ranftler, C., Invernizzi, P., & Penner, E. (2007). Characterization of autoantibodies against components of the nuclear pore complexes: High frequency of anti-p62 nucleoporin antibodies. In Annals of the New York Academy of Sciences (Vol. 1109, pp. 519-530). (Annals of the New York Academy of Sciences; Vol. 1109). https://doi.org/10.1196/annals.1398.058

Characterization of autoantibodies against components of the nuclear pore complexes : High frequency of anti-p62 nucleoporin antibodies. / Wȩsierska-Ga̧dek, Józefa; Klima, Anna; Komina, Oxana; Ranftler, Carmen; Invernizzi, Pietro; Penner, Edward.

Annals of the New York Academy of Sciences. Vol. 1109 2007. p. 519-530 (Annals of the New York Academy of Sciences; Vol. 1109).

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Wȩsierska-Ga̧dek, J, Klima, A, Komina, O, Ranftler, C, Invernizzi, P & Penner, E 2007, Characterization of autoantibodies against components of the nuclear pore complexes: High frequency of anti-p62 nucleoporin antibodies. in Annals of the New York Academy of Sciences. vol. 1109, Annals of the New York Academy of Sciences, vol. 1109, pp. 519-530. https://doi.org/10.1196/annals.1398.058
Wȩsierska-Ga̧dek J, Klima A, Komina O, Ranftler C, Invernizzi P, Penner E. Characterization of autoantibodies against components of the nuclear pore complexes: High frequency of anti-p62 nucleoporin antibodies. In Annals of the New York Academy of Sciences. Vol. 1109. 2007. p. 519-530. (Annals of the New York Academy of Sciences). https://doi.org/10.1196/annals.1398.058
Wȩsierska-Ga̧dek, Józefa ; Klima, Anna ; Komina, Oxana ; Ranftler, Carmen ; Invernizzi, Pietro ; Penner, Edward. / Characterization of autoantibodies against components of the nuclear pore complexes : High frequency of anti-p62 nucleoporin antibodies. Annals of the New York Academy of Sciences. Vol. 1109 2007. pp. 519-530 (Annals of the New York Academy of Sciences).
@inproceedings{49efb75b92c74ca7ae50d2dd07fe0a57,
title = "Characterization of autoantibodies against components of the nuclear pore complexes: High frequency of anti-p62 nucleoporin antibodies",
abstract = "Antibodies against nuclear components (ANAs) occur in sera of approximately 50{\%} of patients with primary biliary cirrhosis (PBC). By indirect immunofluorescence (IIF) ANA-positive PBC sera generate most frequently, homogeneous, speckled, centromere, and rim-like staining patterns. A perinuclear staining pattern is indicative for the reactivity of the sera with the components of the nuclear envelope. A substantial subset of PBC patients develops antibodies against constituents of the nuclear pore complexes (NPCs). These autoantibodies target two major autoantigens: gp210 glycoprotein and p62 kDa nucleoporin. Originally, a strong reaction of PBC with a 60 kDa protein of NPCs that was affinity purified on wheat-germ agglutinin (WGA)-Sepharose was described. Recently, using human recombinant p62 nucleoporin the identity of the reactivitywas confirmed. In this work we compared by immunoprecipitation the reactivity of 20 PBC sera with the two recombinant autoantigens of the NPCs. Two out of 20 (10{\%}) PBC sera precipitated recombinant gp210 glycoprotein and 11 out of 20 (55{\%}) PBC sera reacted with p62 nucleoporin. These results evidence that anti-p62 antibodies occur more frequently than the autoantibodies against gp210 glycoprotein. Considering the recently reported clinical significance of ANAs in PBC, the prognostic value of the anti-NPC antibodies and their correlation with severity and progression of the disease is under evaluation.",
keywords = "AMAs, ANAs, Gp210 glycoprotein, Nuclear envelope, Prognostic value, Severity of disease",
author = "J{\'o}zefa Wȩsierska-Ga̧dek and Anna Klima and Oxana Komina and Carmen Ranftler and Pietro Invernizzi and Edward Penner",
year = "2007",
month = "8",
doi = "10.1196/annals.1398.058",
language = "English (US)",
isbn = "1573316636",
volume = "1109",
series = "Annals of the New York Academy of Sciences",
pages = "519--530",
booktitle = "Annals of the New York Academy of Sciences",

}

TY - GEN

T1 - Characterization of autoantibodies against components of the nuclear pore complexes

T2 - High frequency of anti-p62 nucleoporin antibodies

AU - Wȩsierska-Ga̧dek, Józefa

AU - Klima, Anna

AU - Komina, Oxana

AU - Ranftler, Carmen

AU - Invernizzi, Pietro

AU - Penner, Edward

PY - 2007/8

Y1 - 2007/8

N2 - Antibodies against nuclear components (ANAs) occur in sera of approximately 50% of patients with primary biliary cirrhosis (PBC). By indirect immunofluorescence (IIF) ANA-positive PBC sera generate most frequently, homogeneous, speckled, centromere, and rim-like staining patterns. A perinuclear staining pattern is indicative for the reactivity of the sera with the components of the nuclear envelope. A substantial subset of PBC patients develops antibodies against constituents of the nuclear pore complexes (NPCs). These autoantibodies target two major autoantigens: gp210 glycoprotein and p62 kDa nucleoporin. Originally, a strong reaction of PBC with a 60 kDa protein of NPCs that was affinity purified on wheat-germ agglutinin (WGA)-Sepharose was described. Recently, using human recombinant p62 nucleoporin the identity of the reactivitywas confirmed. In this work we compared by immunoprecipitation the reactivity of 20 PBC sera with the two recombinant autoantigens of the NPCs. Two out of 20 (10%) PBC sera precipitated recombinant gp210 glycoprotein and 11 out of 20 (55%) PBC sera reacted with p62 nucleoporin. These results evidence that anti-p62 antibodies occur more frequently than the autoantibodies against gp210 glycoprotein. Considering the recently reported clinical significance of ANAs in PBC, the prognostic value of the anti-NPC antibodies and their correlation with severity and progression of the disease is under evaluation.

AB - Antibodies against nuclear components (ANAs) occur in sera of approximately 50% of patients with primary biliary cirrhosis (PBC). By indirect immunofluorescence (IIF) ANA-positive PBC sera generate most frequently, homogeneous, speckled, centromere, and rim-like staining patterns. A perinuclear staining pattern is indicative for the reactivity of the sera with the components of the nuclear envelope. A substantial subset of PBC patients develops antibodies against constituents of the nuclear pore complexes (NPCs). These autoantibodies target two major autoantigens: gp210 glycoprotein and p62 kDa nucleoporin. Originally, a strong reaction of PBC with a 60 kDa protein of NPCs that was affinity purified on wheat-germ agglutinin (WGA)-Sepharose was described. Recently, using human recombinant p62 nucleoporin the identity of the reactivitywas confirmed. In this work we compared by immunoprecipitation the reactivity of 20 PBC sera with the two recombinant autoantigens of the NPCs. Two out of 20 (10%) PBC sera precipitated recombinant gp210 glycoprotein and 11 out of 20 (55%) PBC sera reacted with p62 nucleoporin. These results evidence that anti-p62 antibodies occur more frequently than the autoantibodies against gp210 glycoprotein. Considering the recently reported clinical significance of ANAs in PBC, the prognostic value of the anti-NPC antibodies and their correlation with severity and progression of the disease is under evaluation.

KW - AMAs

KW - ANAs

KW - Gp210 glycoprotein

KW - Nuclear envelope

KW - Prognostic value

KW - Severity of disease

UR - http://www.scopus.com/inward/record.url?scp=34848847520&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34848847520&partnerID=8YFLogxK

U2 - 10.1196/annals.1398.058

DO - 10.1196/annals.1398.058

M3 - Conference contribution

C2 - 17785341

AN - SCOPUS:34848847520

SN - 1573316636

SN - 9781573316637

VL - 1109

T3 - Annals of the New York Academy of Sciences

SP - 519

EP - 530

BT - Annals of the New York Academy of Sciences

ER -